Bristol-Myers Squibb Co (NYSE:BMY)

65.32
Delayed Data
As of May 04
 +0.66 / +1.02%
Today’s Change
46.30
Today|||52-Week Range
69.20
+10.66%
Year-to-Date
Global spending on cancer drugs surges to $100bn
12:12am / FT.com
S&P Futures Hug 2100 After China Denies QE, European Stocks Slide
Apr 28 / Investing Channel
Novo Nordisk (NVO) Beats on Q1 Earnings, Updates Outlook - Analyst Blog
May 04 / Zacks.com
Earnings Scheduled For April 28, 2015
Apr 28 / Benzinga
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, Biogen, Actelion and Horizon...
May 04 / Zacks.com
Will Generics & Currency Hit Pfizer (PFE) Q1 Earnings? - Analyst Blog
Apr 27 / Zacks.com
The Tiny Biotech Getting Free Lunch from Big Pharma
May 03 / MotleyFool.com
Gilead and Bristol-Myers Reveal Positive Data on HCV Drugs - Analyst Blog
Apr 27 / Zacks.com
Bristol-Myers Squibb Outpaces AbbVie in Hepatitis C
May 02 / MotleyFool.com
Will Bristol-Myers (BMY) Earnings Streak Continue in Q1? - Analyst Blog
Apr 27 / Zacks.com
Bristol-Myers' Supplemental BLA for Opdivo Accepted by FDA - Analyst Blog
May 01 / Zacks.com
Will Express Scripts (ESRX) Disappoint Earnings in Q1? - Analyst Blog
Apr 27 / Zacks.com
Seattle Genetics, Inc. Posts Solid First-Quarter Revenue, Raises Expense Guidance
Apr 30 / MotleyFool.com
Will Merck's (MRK) Q1 Earnings be Hit by Generics & Currency? - Analyst Blog
Apr 27 / Zacks.com
Celldex 1Q Loss Narrower-Than-Expected, Pipeline in Focus - Analyst Blog
Apr 29 / Zacks.com
Mylan rounds on Teva as it rejects $40bn bid
Apr 27 / FT.com
Merck & Co., Inc. Earnings: 3 Big Surprises You Won't Read in the Headlines
Apr 29 / MotleyFool.com
AstraZeneca forced to defend cancer drug deal with Celgene
Apr 24 / FT.com
Bristol-Myers Squibb (BMY) Earnings Report: Q1 2015 Conference Call Transcript
Apr 29 / TheStreet.com
Will Biogen's (BIIB) Earnings Streak Continue in 1Q? - Analyst Blog
Apr 23 / Zacks.com
2 Stocks to Buy in a Biotech Crash
Apr 28 / MotleyFool.com
Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?
Apr 22 / MotleyFool.com
Bristol-Myers Q1 Earnings Beat Driven by Strong Sales - Analyst Blog
Apr 28 / Zacks.com
Roche boosted by US drugs sales
Apr 22 / FT.com
Bristol-Myers Squibb Crushes First-Quarter Earnings: Here's Why
Apr 28 / MotleyFool.com
Bristol-Myers Announces Positive Data from Opdivo Study - Analyst Blog
Apr 21 / Zacks.com
Bristol-Myers Squibb (BMY) Stock Declines Despite Strong Financial Quarter
Apr 28 / TheStreet.com
Seattle Genetics' Adcetris Under Review for New Indication - Analyst Blog
Apr 21 / Zacks.com
Bristol-Myers (BMY) Beats on Q1 Earnings, Share Up - Tale of the Tape
Apr 28 / Zacks.com
Bristol-Myers combination melanoma treatment shows promise
Apr 20 / FT.com
Trade-Ideas: Bristol-Myers Squibb Company (BMY) Is Today's Pre-Market Leader Stock
Apr 28 / TheStreet.com
Biotech: Making sense of the science
Apr 13 / FT.com
First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast
Apr 28 / TheStreet.com
Big pharma turns to small biotechs for edge in cancer treatment
Apr 07 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account